缺血性中风中的胆代谢:一个被低估的"双刃剑"
Mengchen Yu1, Guohao Liu1, Wenbo Chen1
1Department of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong University, Jinan 250012, China; Shandong Key Laboratory of Brain Health and Function Remodeling, Jinan 250012, China.
Pharmacological research
|March 7, 2025
概括
胆代谢通过神经保护和再生影响缺血性中风 (IS). 均衡饮食胆至关重要,因为虽然它有好处,但过量摄入或某些代谢物可能会带来风险.
科学领域:
- 神经科学是一个神经科学.
- 代谢研究研究 代谢研究
- 心血管健康 心血管健康
背景情况:
- 缺血性中风 (IS) 是全球死亡和残疾的主要原因.
- 基于IS的精确分子机制仍然不完全理解.
- 胆代谢正在成为IS病变和进展的关键因素.
研究的目的:
- 审查胆代谢在缺血性中风中的多方面的作用.
- 突出肠道微生物群,胆代谢物和脑血管健康之间的联系.
- 为临床干预和中风预防策略提供理论基础.
主要方法:
- 文献综述整合了有关胆代谢和缺血性中风的当前研究.
- 对胆神经保护和神经再生功能的分析.
- 检查胆代谢物,如三甲基胺-N-氧化物 (TMAO),对IS的影响.
主要成果:
- 胆代谢通过神经保护,神经再生和免疫调节影响IS.
- 肠道微生物群通过胆代谢显著影响大脑血管健康.
- 确定了胆及其代谢物对IS的保护性和潜在风险性影响.
结论:
- 饮食中胆的摄入需要谨慎的平衡,因为与过度消费或特定代谢物相关的潜在风险.
- 了解胆代谢为IS的预后评估和治疗提供了新的视角.
- 对胆代谢的进一步研究可以优化中风预防和管理策略,促进心脏和大脑健康.
相关概念视频
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.0K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.0K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.5K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
88
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
88
Anticholinesterase Agents: Poisoning and Treatment
772
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
772
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
600
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
600
Depolarizing Blockers: Pharmocokinetics
299
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
299


